The coming of age of virus-like particle vaccines (Q37309265)

From Wikidata

Revision as of 07:53, 21 July 2024 by ԱշբոտՏՆՂ (talk | contribs) (‎Added [hy] description: գիտական հոդված հրատարակված 2008 թվականի մայիսին, based on en:scientific article published on May 2008)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on May 2008

Language	Label	Description	Also known as
English	The coming of age of virus-like particle vaccines	scientific article published on May 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

The coming of age of virus-like particle vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

0 references

0 references

Martin F. Bachmann

2

object named as

Martin F Bachmann

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

author name string

Gary T Jennings

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

389

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

521-536

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Renin-angiotensin vaccine: old story, new project 'efficacy versus safety'.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Specific cellular stimulation in the primary immune response: experimental test of a quantized model

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

The influence of virus structure on antibody responses and virus serotype formation

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Natural supramolecular building blocks. Cysteine-added mutants of cowpea mosaic virus

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Role of Toll-like receptors in costimulating cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

A Viral Platform for Chemical Modification and Multivalent Display

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Mosaic hepatitis B virus core particles presenting the complete preS sequence of the viral envelope on their surface

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

The economic impact of hypertension

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

HBV core particles as a carrier for B cell/T cell epitopes

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Neutralizing antiviral B cell responses

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Structures of virus and virus-like particles

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Multiple chemical forms of hepatitis B surface antigen produced in yeast

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Therapeutic potential of Toll-like receptor 9 activation

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Virus-like particles: passport to immune recognition

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Immunotherapy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.064

21 January 2018

Identifiers

10.1515/BC.2008.064

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37309265&oldid=2209285919"